Here, we demonstrate that aggregation of the prion-like domain of hnRNPA1 (A1PrD), implicated in AD and ALS, is driven by solution composition and phase transition dynamics. The gene discussed is HNRNPA1; the disease is amyotrophic lateral sclerosis.